Corporate Governance Corporate Governance Overview Delivery How our governance supports the delivery of our strategy All Directors are collectively responsible for the success of the Group.
The Non-Executive Directors exercise independent, objective judgement in respect of Board decisions, and scrutinise and challenge management.
They also have various responsibilities concerning the integrity of financial information, internal controls and risk management.
The Board is responsible for setting our strategy stakeholders.
The Board conducts an annual and policies, overseeing risk and corporate review of the Groups overall strategy.
The CEO, governance, and monitoring progress towards CFO and Senior Executive Team SET take the meeting our objectives and annual plans.
It is lead in developing our strategy, which is then accountable to our shareholders for the proper reviewed, constructively challenged and conduct of the business and our long-term success, approvedby the Board.
and seeks to represent the interests of all Governance structure The Board has delegated some of its powers to the CEO and operates with the assistance of four Committees: Board Corporate Governance Report on page 98 Audit Remuneration Nomination and Science Committee Committee Governance Committee Committee Report from page 110 Report from page 120 Report from page 108 Report from page 107 In addition to the SET, we have two senior level governance bodies: Senior Executive Team SET Details of our SET on page 96 Early Stage Product Committees Late Stage Product Committee Page 96 Page 96 Following the organisational changes announced in January 2019, the future and structure of these governance bodies will be reviewed in the first quarter of 2019.
For more information, see page 96.
Attendance in 2018 Board Committee membership and meeting attendance in 2018 Nomination and Name Board Audit Remuneration Governance Science Board or Committee Chairman Genevive Berger 13 13 2 2 Philip Broadley 13 13 6 6 1 1 Graham Chipchase 13 13 6 6 5 5 Deborah DiSanzo 13 13 2 2 Marc Dunoyer 13 13 Leif Johansson 13 13 5 6 5 5 Rudy Markham 12 13 6 6 5 6 5 5 Sheri McCoy 13 13 6 6 2 2 Nazneen Rahman 13 13 3 3 2 2 Pascal Soriot 13 13 Shriti Vadera retired 31 December 2018 13 13 3 3 6 6 Marcus Wallenberg 11 13 2 2 Note: number in brackets denotes number of meetings during the year that Board members were entitled to attend.
F or more information, see Changes to the composition of the Board and its Committees for the year ended 31 December 2018 on page 94 AstraZeneca Annual Report & Form 20-F Information 2018 Corporate Governance Report 93
